Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-23

Clinical Trial Update: The Effects of Caffeine Withdrawal on Migraine [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial investigating the effects of caffeine withdrawal on migraine; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Nordlandssykehuset HF | Conditions: Migraine, Caffeine Withdrawal | Phase 2, Phase 3 | Status: TERMINATED